Targeting Programmed Cell Death -1 (PD-1) and Ligand (PD-L1): A new era in cancer active immunotherapy

Autor:	Constantinidou, Anastasia, Alifieris, Constantinos, Trafalis, Dimitrios T.
Zdroj:	In Pharmacology and Therapeutics February 2019 194:84-106
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect